Regenerative medicine plays an important role in the medical community and care continuum. By using human cell and tissue products to create an optimal internal healing environment it gives patients and professionals new treatment options that weren’t available just a few years ago.
In order to be effective, you have to put in the work. That’s why Predictive insists on the rigorous research behind every product we develop. By going the extra step to identify the optimal tissue source from which to derive our human cell and tissue products (HCT/Ps), we hope to better support the body’s natural regenerative environment, and aid in its repair. Each of our four signature products has years of research behind it, is thoroughly tested, verified by independent parties and meticulously handled from our own labs to medical offices nationwide. Why? Because our products have a purpose that’s bigger than just business: to help heal everybody.
In the emerging field of regenerative medicine, Predictive is setting the bar high for processing protocol. The power of our products is in their functionality, but just like all harvested tissue, that functionality can diminish without proper handling. That’s why we process all of our tissues in our FDA-registered lab utilizing proprietary methods that reduce the loss of important scaffolding proteins, growth factors, cytokines and other properties. We then cryogenically freeze the allograft to better preserve viability and even go so far as to provide liquid nitrogen storage containers to our medical partners to ensure the product is kept at -196 degrees Celsius. It’s about minimally processing tissue to preserve and share what matters so we can maximize its potential.
AmnioCyte™ is a minimally manipulated human tissue allograft derived from amniotic fluid. AmnioCyte™ is processed to preserve the cytokines, growth factors and proteins in amniotic fluid for homologous use.
AmnioCyte Plus™ is a minimally manipulated human tissue allograft derived from the extracellular matrix of the amniotic membrane. AmnioCyte Plus™ is processed to preserve cytokines, growth factors and scaffolding proteins in the amniotic membrane for homologous use.
PolyCyte™ is a minimally manipulated human tissue allograft derived from the Wharton’s jelly of the umbilical cord. PolyCyte™ is processed to preserve cytokines, growth factors, and proteins of Wharton’s jelly for homologous use.
CoreCyte™ is a minimally manipulated human tissue allograft derived from the Wharton’s jelly of the umbilical cord. CoreCyte™ is processed to preserve the integrity of Wharton’s jelly for homologous use and cryogenically preserved.
One of the many things that separates Predictive Biotech from other regenerative medicine companies is its absolute insistence on best-in-class handling of its products. It’s not enough to package something and send it to market. To truly help everybody we need to do all we can to ensure functionality. That hinges on our cryopreservation system. Not only do we promptly cryogenically freeze our allografts after processing, but we even go the extra step to deliver special Cryotanks to each of our medical partners, complete with instructions for how to maintain it and its contents. This is essential in offering the most promise to all patients using our products.
Medicine that's based on you
The body is a powerful thing: constructed with the building blocks needed to help heal itself. But as the body ages, those regenerative abilities slow dramatically and we are left with the question: is there a way to supplement our body's ability to heal itself? We believe so.
Standards that matter
Predictive Biotech is committed to truth, trust and transparency. We set high standards and hold ourselves to them by being honest with our clients and being meticulous with our processing ensuring optimal viability of every allograft. It's a better way to treat people—and it starts here.
Repair that starts within
Regenerative medicine plays an important role in the care continuum. Using human cell and tissue products to support the optimal internal healing environment gives patients and professionals new treatment options that weren’t available just a few years ago.
More than just stem cells
There is much in the news about stem cells. To characterize regenerative medicine as just stem cells is not only incorrect it is not in compliance with FDA guidelines. Predictive Biotech continues to research and analyze the intricate relationship of contributing factors needed to help the body repair, replace, cushion, support, protect and function at optimal levels. It’s that thorough understanding of all the parts that make the whole that enables us to create market leading products.
and see how regenerative medicine can help you.
Enter your text here...